176 related articles for article (PubMed ID: 32833540)
1. Severe Antithrombin Deficiency May be Associated With a High Risk of Pathological Progression of DIC With Suppressed Fibrinolysis.
Wada H; Honda G; Kawano N; Uchiyama T; Kawasugi K; Madoiwa S; Takezako N; Suzuki K; Seki Y; Ikezoe T; Iba T; Okamoto K
Clin Appl Thromb Hemost; 2020; 26():1076029620941112. PubMed ID: 32833540
[TBL] [Abstract][Full Text] [Related]
2. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies.
Fourrier F; Chopin C; Goudemand J; Hendrycx S; Caron C; Rime A; Marey A; Lestavel P
Chest; 1992 Mar; 101(3):816-23. PubMed ID: 1531791
[TBL] [Abstract][Full Text] [Related]
3. Association of antithrombin with development of trauma-induced disseminated intravascular coagulation and outcomes.
Wada T; Shiraishi A; Gando S; Kabata D; Yamakawa K; Fujishima S; Saitoh D; Kushimoto S; Ogura H; Abe T; Mayumi T; Otomo Y
Front Immunol; 2022; 13():1026163. PubMed ID: 36569855
[TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
[TBL] [Abstract][Full Text] [Related]
5. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
6. A Pathological Clarification of Sepsis-Associated Disseminated Intravascular Coagulation Based on Comprehensive Coagulation and Fibrinolysis Function.
Onishi T; Nogami K; Ishihara T; Inoue S; Kawaguchi M; Nishio K; Fukushima H; Kobayashi H; Amano I; Nishikubo T; Yamasaki M; Kasahara M; Shima M
Thromb Haemost; 2020 Sep; 120(9):1257-1269. PubMed ID: 32679594
[TBL] [Abstract][Full Text] [Related]
7. Normal prothrombinase activity, increased systemic thrombin activity, and lower antithrombin levels in patients with disseminated intravascular coagulation at an early phase of trauma: comparison with acute coagulopathy of trauma-shock.
Yanagida Y; Gando S; Sawamura A; Hayakawa M; Uegaki S; Kubota N; Homma T; Ono Y; Honma Y; Wada T; Jesmin S
Surgery; 2013 Jul; 154(1):48-57. PubMed ID: 23684364
[TBL] [Abstract][Full Text] [Related]
8. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
[TBL] [Abstract][Full Text] [Related]
9. Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin.
Wada H; Kawasugi K; Honda G; Kawano N; Uchiyama T; Madoiwa S; Takezako N; Suzuki K; Seki Y; Ikezoe T; Iba T; Okamoto K
TH Open; 2023 Jan; 7(1):e65-e75. PubMed ID: 36846833
[No Abstract] [Full Text] [Related]
10. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
[TBL] [Abstract][Full Text] [Related]
11. Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury.
Wada T; Gando S; Maekaw K; Katabami K; Sageshima H; Hayakawa M; Sawamura A
Crit Care; 2017 Aug; 21(1):219. PubMed ID: 28826407
[TBL] [Abstract][Full Text] [Related]
12. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
Iba T; Thachil J
Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan.
Taniguchi K; Ohbe H; Yamakawa K; Matsui H; Fushimi K; Yasunaga H
BMC Cancer; 2020 Sep; 20(1):867. PubMed ID: 32907555
[TBL] [Abstract][Full Text] [Related]
14. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure.
Kuroda H; Masuda Y
Clin Appl Thromb Hemost; 2020; 26():1076029620981630. PubMed ID: 33332196
[TBL] [Abstract][Full Text] [Related]
16. Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa.
Kawasugi K; Wada H; Honda G; Kawano N; Uchiyama T; Madoiwa S; Takezako N; Suzuki K; Seki Y; Ikezoe T; Iba T; Okamoto K
Thromb J; 2021 Feb; 19(1):12. PubMed ID: 33632246
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.
Yamada S; Asakura H
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163216
[TBL] [Abstract][Full Text] [Related]
18. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.
Asakura H; Takahashi H; Tsuji H; Matsushita T; Ninomiya H; Honda G; Mimuro J; Eguchi Y; Kitajima I; Sakata Y
Thromb Res; 2014 Mar; 133(3):364-70. PubMed ID: 24440141
[TBL] [Abstract][Full Text] [Related]
19. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
Matsuo T; Matsuo M; Sugimoto T; Wanaka K
Pathophysiol Haemost Thromb; 2007; 36(6):305-10. PubMed ID: 20224256
[TBL] [Abstract][Full Text] [Related]
20. Hypercoagulation and hypofibrinolysis in horses with colic and DIC.
Monreal L; Anglés A; Espada Y; Monasterio J; Monreal M
Equine Vet J Suppl; 2000 Jun; (32):19-25. PubMed ID: 11202377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
